Olbrich S

Hospital for Psychiatry, Psychotherapy and Psychosomatic, University Zurich, Zurich, Switzerland.

2 preprints · 8 papers · ORCID

PreprintKetamine

Esketamine for treatment-resistant depression: Comparing two maintenance schedules in an observational real-world study

Westenhöfer S, Ehrt Y, Provaznikova B +9

ArticleKetamine

Ketamine alters the aperiodic EEG exponent in major depression: implications for cortical E/I balance and treatment prediction.

Liu Y, Liu X, Olbrich S +4

ArticleKetamine

Ketamine-Assisted Psychotherapy for Posttraumatic Stress Disorder: A Systematic Review and Individual Participant Data Meta-Analysis of Predictors of Treatment Effects.

Rohde J, Moore TM, Walker K +11

ArticlePsilocybin

Real-World Psilocybin Therapy for Treatment-Resistant Depression: A Retrospective Observational Study.

Jungwirth J, Westenhöfer S, Aicher HD +5

ArticlePsilocybin

Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applications.

Ip CT, Olbrich S, de Bardeci M +4

PreprintPsilocybin

Real-World Psilocybin Therapy for Treatment-Resistant Depression: a Retrospective Observational Study

Jungwirth J, Westenhöfer S, Aicher H +5

ArticleKetamine

The role of frontal EEG in predicting clinical response of major depressive disorder to intranasal ketamine and esketamine.

Trenado C, Seifritz E, Olbrich S +1

ArticleKetamine

[Interventional psychiatric procedures and novel substances for the treatment of affective disorders: An overview and outlook].

Bracht T, Hubl D, Adorjan K +6

ArticleKetamine

Combined Effects of Nasal Ketamine and Trauma-Focused Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder: A Pilot Case Series.

Rohde J, Hickmann E, Buchmann M +5

LSD and ketanserin and their impact on the human autonomic nervous system.

Olbrich S, Preller KH, Vollenweider FX